Literature DB >> 18827620

Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007.

Eric Lim1, Peter Goldstraw, Andrew G Nicholson, William D Travis, James R Jett, Piero Ferolla, Jamshed Bomanji, Valerie W Rusch, Hisao Asamura, Britt Skogseid, Eric Baudin, Martyn Caplin, Dik Kwekkeboom, Elisabeth Brambilla, John Crowley.   

Abstract

The International Association for the Study of Lung Cancer, (IASLC) International Congress on Advances in Pulmonary Neuroendocrine Tumors was a two-day meeting held at the Royal Brompton Hospital in London, United Kingdom on the thirteenth and forteenth of December 2007. The meeting was led by 14 member international faculty-in the disciplines of pathology, surgery, medicine, oncology, endocrinology, nuclear medicine, diagnostic imaging, and biostatistics. The aims were twofold, as an educational meeting, and to develop the IASLC International Pulmonary Neuroendocrine Tumors Registry. The meeting highlighted the difference in presentation of the tumors, management options for early and advanced stage disease including the use of novel agents and approaches. The need, process, and approach to an International Registry of Pulmonary Neuroendocrine Tumors were emphasized. International collaboration to develop a retrospective registry, prospective data collection, virtual tissue bank, and collaborative clinical trials were universally agreed as the best way to advance our understanding and treatment of these rare tumors.

Entities:  

Mesh:

Year:  2008        PMID: 18827620     DOI: 10.1097/JTO.0b013e3181861d7b

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  21 in total

1.  Deletions of 11q22.3-q25 are associated with atypical lung carcinoids and poor clinical outcome.

Authors:  Dorian R A Swarts; Sandra M H Claessen; Yvonne M H Jonkers; Robert-Jan van Suylen; Anne-Marie C Dingemans; Wouter W de Herder; Ronald R de Krijger; Egbert F Smit; Frederik B J M Thunnissen; Cornelis A Seldenrijk; Aryan Vink; Aurel Perren; Frans C S Ramaekers; Ernst-Jan M Speel
Journal:  Am J Pathol       Date:  2011-07-16       Impact factor: 4.307

2.  Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study.

Authors:  A Faggiano; P Ferolla; F Grimaldi; D Campana; M Manzoni; M V Davì; A Bianchi; R Valcavi; E Papini; D Giuffrida; D Ferone; G Fanciulli; G Arnaldi; G M Franchi; G Francia; G Fasola; L Crinò; A Pontecorvi; P Tomassetti; A Colao
Journal:  J Endocrinol Invest       Date:  2011-11-09       Impact factor: 4.256

Review 3.  Advanced typical and atypical carcinoid tumours of the lung: management recommendations.

Authors:  B Melosky
Journal:  Curr Oncol       Date:  2018-06-13       Impact factor: 3.677

4.  Two cases of the bronchial carcinoid tumors successfully treated with the parenchymal-sparing bronchoplastic resections.

Authors:  Katarzyna Drożdż; Mariusz Chabowski; Angelika Chachaj; Paweł Gać; Małgorzata Szołkowska; Dariusz Janczak; Andrzej Szuba
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

Review 5.  Treatment of Lung Carcinosarcoma and Other Rare Histologic Subtypes of Non-small Cell Lung Cancer.

Authors:  Han Yang; Yongbin Lin; Ying Liang
Journal:  Curr Treat Options Oncol       Date:  2017-08-10

6.  Peptide receptor radionuclide therapy with (177)Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and (18)F-FDG PET.

Authors:  Annarita Ianniello; Maddalena Sansovini; Stefano Severi; Silvia Nicolini; Chiara Maria Grana; Katrin Massri; Alberto Bongiovanni; Lorenzo Antonuzzo; Valentina Di Iorio; Anna Sarnelli; Paola Caroli; Manuela Monti; Emanuela Scarpi; Giovanni Paganelli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-27       Impact factor: 9.236

Review 7.  The Diagnosis and Treatment of Bronchopulmonary Carcinoid.

Authors:  Jussuf T Kaifi; Gian Kayser; Juri Ruf; Bernward Passlick
Journal:  Dtsch Arztebl Int       Date:  2015-07-06       Impact factor: 5.594

8.  Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  David E Ost; Sai-Ching Jim Yeung; Lynn T Tanoue; Michael K Gould
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

9.  Surgical Resection for Pulmonary Carcinoid: Long-Term Results of Multicentric Study-The Importance of Pathological N Status, More Than We Thought.

Authors:  Giacomo Cusumano; Ludovic Fournel; Salvatore Strano; Diane Damotte; Marie Christine Charpentier; Antonio Galia; Alberto Terminella; Maurizio Nicolosi; Jean Francois Regnard; Marco Alifano
Journal:  Lung       Date:  2017-10-11       Impact factor: 2.584

Review 10.  [Pulmonary carcinoids and carcinoids of the small intestine].

Authors:  K S Winter; C J Auernhammer; A Todica; J Ricke; C Cyran
Journal:  Radiologe       Date:  2019-11       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.